Acambis news from FierceVaccines
NewsSPOTLIGHT: Acambis contract offers long-term funding
The announcement that Acambis has won a $425 million, 10-year contract to supply the U.S. government with its smallpox vaccine, along with a new share placement, will provide the company with enough Read more...
Out with old, in with new smallpox vaccine
With a new smallpox vaccine accumulating in federal stockpiles, the U.S. government is disposing of millions of doses of Dryvax, the old smallpox vaccine that relies on skin scrapings from infected Read more...
Universal flu vaccine shows early promise
Acambis has stirred a significant amount of buzz with some early-stage human data demonstrating the effectiveness of its Read more...
Acambis takes aim at proof-of-concept vaccine trial
Taking aim at the leading cause of hospital-acquired diarrhea, Clostridium difficile, Acambis has completed its prep work for a proof-of-concept trial late next year. During Phase I testing involving Read more...
| Press ReleasesAcambis reports positive data from trials of universal influenza A vaccine Acambis reports positive data from trials of universal influenza A vaccine Cambridge, UK and Cambridge, Massachusetts – 3 January 2008 – Acambis plc (Acambis) (LSE: ACM), a leading vaccine Read more... PRESS RELEASE: Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine CAMBRIDGE, England and CAMBRIDGE, Massachusetts, November 1 - No Human Vaccine Currently Exists Against the West Nile Read more... PRESS RELEASE: FDA Approves ACAM2000 Vaccine for Protection Against Smallpox FDA Approves ACAM2000 Vaccine for Protection Against Smallpox CAMBRIDGE, England and CAMBRIDGE, Massachusetts, September 3 /PRNewswire-FirstCall/ -- Acambis plc (Acambis) , a leading vaccine Read more... |
Get more Acambis coverage at:
Paid Research Reports
- Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
- Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
- Biotech 2008 – life sciences industry report (online & print)
- Is there a market for alcoholism pharmacotherapies?
- New report provides Rheumatoid Arthritis market insight